C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19

Objective: To compare the C-reactive proteinlevels in different groups of COVID-19 patients to assess disease severity. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hospital Kohat, from Apr 2020 to Jun2020. Methodology: Forty fiveConfirmed cases of COV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mirza Waseem Javed, Muhammad Anwar, Tariq Mehmood Bangash, Rizwan Ul Haq Satti, Mehar Rehman, Uzair Ijaz Malik
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doaj.org/article/50dfd564b9904270a92926c9d0b2ebad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:50dfd564b9904270a92926c9d0b2ebad
record_format dspace
spelling oai:doaj.org-article:50dfd564b9904270a92926c9d0b2ebad2021-12-02T17:41:46ZC-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-190030-96482411-8842https://doaj.org/article/50dfd564b9904270a92926c9d0b2ebad2020-09-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/5320https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To compare the C-reactive proteinlevels in different groups of COVID-19 patients to assess disease severity. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hospital Kohat, from Apr 2020 to Jun2020. Methodology: Forty fiveConfirmed cases of COVID-19 patients were included by non-probability consecutive sampling. Patients were divided into five groups (Asymptomatic, Mild, Moderate, Severe and Critical). Serum sample for C -reactiveprotein levels were collected at presentation and compared in different clinical groups by Paired sample “t” test andoneway Anova(Post Hoc LSD). Result: Out of 45 cases in our study28 (62.2%) were male and 17 (37.8%) were female. Mean age of patients was 51.96 ± 16 and mean C-reactiveproteinlevels were 76.61± 75 mg/L. When compared by paired sample t-test C-reactive proteinlevels were: higherin the mild patient group than asymptomatic group, higher inthe moderate groupthan mild group, higherin severe group than moderate group and those in the critical group were higherthan those in the severe group. The difference was statistically significant with p-value <0.05 in each group. Conclusion: C-reactive proteinlevelswerelowest in asymptomatic and highest in critical patients inearly COVID-19. This may help guide management.Mirza Waseem JavedMuhammad AnwarTariq Mehmood BangashRizwan Ul Haq SattiMehar RehmanUzair Ijaz MalikArmy Medical College Rawalpindiarticlecovid-19c-reactive proteindisease severity classificationMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 2, Pp 603-607 (2020)
institution DOAJ
collection DOAJ
language EN
topic covid-19
c-reactive protein
disease severity classification
Medicine
R
Medicine (General)
R5-920
spellingShingle covid-19
c-reactive protein
disease severity classification
Medicine
R
Medicine (General)
R5-920
Mirza Waseem Javed
Muhammad Anwar
Tariq Mehmood Bangash
Rizwan Ul Haq Satti
Mehar Rehman
Uzair Ijaz Malik
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
description Objective: To compare the C-reactive proteinlevels in different groups of COVID-19 patients to assess disease severity. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hospital Kohat, from Apr 2020 to Jun2020. Methodology: Forty fiveConfirmed cases of COVID-19 patients were included by non-probability consecutive sampling. Patients were divided into five groups (Asymptomatic, Mild, Moderate, Severe and Critical). Serum sample for C -reactiveprotein levels were collected at presentation and compared in different clinical groups by Paired sample “t” test andoneway Anova(Post Hoc LSD). Result: Out of 45 cases in our study28 (62.2%) were male and 17 (37.8%) were female. Mean age of patients was 51.96 ± 16 and mean C-reactiveproteinlevels were 76.61± 75 mg/L. When compared by paired sample t-test C-reactive proteinlevels were: higherin the mild patient group than asymptomatic group, higher inthe moderate groupthan mild group, higherin severe group than moderate group and those in the critical group were higherthan those in the severe group. The difference was statistically significant with p-value <0.05 in each group. Conclusion: C-reactive proteinlevelswerelowest in asymptomatic and highest in critical patients inearly COVID-19. This may help guide management.
format article
author Mirza Waseem Javed
Muhammad Anwar
Tariq Mehmood Bangash
Rizwan Ul Haq Satti
Mehar Rehman
Uzair Ijaz Malik
author_facet Mirza Waseem Javed
Muhammad Anwar
Tariq Mehmood Bangash
Rizwan Ul Haq Satti
Mehar Rehman
Uzair Ijaz Malik
author_sort Mirza Waseem Javed
title C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
title_short C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
title_full C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
title_fullStr C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
title_full_unstemmed C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
title_sort c-reactive protein levels and the severity of covid-19
publisher Army Medical College Rawalpindi
publishDate 2020
url https://doaj.org/article/50dfd564b9904270a92926c9d0b2ebad
work_keys_str_mv AT mirzawaseemjaved creactiveproteinlevelsandtheseverityofcovid19
AT muhammadanwar creactiveproteinlevelsandtheseverityofcovid19
AT tariqmehmoodbangash creactiveproteinlevelsandtheseverityofcovid19
AT rizwanulhaqsatti creactiveproteinlevelsandtheseverityofcovid19
AT meharrehman creactiveproteinlevelsandtheseverityofcovid19
AT uzairijazmalik creactiveproteinlevelsandtheseverityofcovid19
_version_ 1718379644079570944